Oral Corticosteroids for Muscle-Related Pain in Radiculopathy
Oral corticosteroids do NOT effectively relieve pain associated with radiculopathy, though they may provide modest functional improvement at the cost of significant adverse effects.
Evidence Summary
The most authoritative evidence comes from the 2017 American College of Physicians systematic review, which found that systemic corticosteroids consistently showed no differences versus placebo in pain relief for radicular low back pain across 6 trials 1. This is moderate-strength evidence from multiple good-quality trials.
Pain Outcomes (The Primary Concern)
- Six trials consistently found NO pain reduction with oral corticosteroids versus placebo for radicular pain 1
- The largest high-quality trial (n=269) showed no improvement in leg pain at 3 weeks (0.3-point difference, not significant) or 52 weeks (0.6-point difference, not significant) 2
- While one small trial in cervical radiculopathy showed pain improvement 3, this contradicts the larger body of lumbar evidence and represents a different anatomical region
Functional Outcomes (Secondary Finding)
The evidence shows a disconnect between pain and function:
- The largest trial found a small functional improvement (7.4-point ODI difference at 52 weeks) 2
- However, this functional benefit occurred without corresponding pain relief 1, 2
- Two other trials found no functional effects at all 1
Harm Profile
Oral corticosteroids significantly increase adverse events:
- 49% versus 24% experiencing any adverse event (p<0.001) 1, 2
- Specific increases in insomnia (26% vs 10%), nervousness (18% vs 8%), and increased appetite (22% vs 10%) 1
- These harms occur without meaningful pain benefit
Clinical Algorithm
For muscle-related pain from radiculopathy:
Do NOT use oral corticosteroids as primary pain management - they don't work for pain 1
Consider alternative approaches:
If considering oral steroids despite evidence:
- Only justify if severe functional disability is the primary concern (not pain)
- Use short courses only (15 days maximum)
- Counsel patients that pain relief is unlikely but function may modestly improve
- Monitor for common adverse effects
Critical Pitfalls
- Don't confuse functional improvement with pain relief - the evidence shows these can diverge
- Don't extrapolate from cervical to lumbar radiculopathy - the evidence base differs
- Don't use oral steroids for "muscle pain" - radiculopathy is neuropathic pain, not muscular, and corticosteroids don't address either component effectively
- Don't ignore the harm profile - nearly half of patients experience adverse effects for minimal to no pain benefit
The British Pain Society pathway appropriately emphasizes that neuropathic pain from radiculopathy often responds poorly to simple analgesics and requires recognition as a distinct entity 5. Oral corticosteroids fall into the category of treatments with poor evidence for radicular pain specifically.